跳至主要内容
临床试验/JPRN-UMIN000013234
JPRN-UMIN000013234已完成未知

Effect of the dual treatment of diquafosol sodium and rebamipide on dry eye syndrome related to chronic graft versus host disease and Sjogrens syndrome - Effect of diquafosol sodium and rebamipide on GVHD and Sjogrens syndrome related dry eye.

Keio University School of Medicine0 个研究点目标入组 20 人开始时间: 2014年4月1日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
入组人数
20

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 75years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1, Dry eye syndrome severity level 4 (dry eye workshop classification 2007) 2, Patients dosed diquafosol sodium and / or rebamipide ophthalmic solution 3, Patients having a concern of becoming severe dry eye because of having GVHD in other organs and so on 4, Patients with ocular pemphigoid, and Stevens-Johnson syndrome 5, Patients with a history of ophthalmic surgery within 6 months before the study 6, Patients wearing contact lens 7, Patients who will be applied radiation treatment during the study 8, Patients dosed cevimeline hydrochloride hydrate and /or pilocarpine(eye drop or oral drug) 9, Patients who will be ineligible for registration the study

研究者

相似试验

Effect of the dual treatment of diquafosol sodium... | 临床试验